RUNX1 and acute lymphoblastic leukemia: Although the REH ALL cells are considered resistant to treatment, other conditions have also been associated with ASNase treatment resistance such as the expression of asparagine synthetase in ETV6–RUNX1 cell lines, which may be related to an inferior outcome for patients.